Biblio

Found 5 results

Filters: Keyword is Proportional Hazards Models [Clear All Filters]

2015

Schrepf A, Thaker PH, Goodheart MJ, Bender D, Slavich GM, Dahmoush L, Penedo F, DeGeest K, Mendez L, Lubaroff DM et al.. 2015. Diurnal cortisol and survival in epithelial ovarian cancer.. Psychoneuroendocrinology. 53:256-67.

2013

Sørensen GVrelits, Ganz PA, Cole SW, Pedersen LA, Sørensen HToft, Cronin-Fenton DP, Garne JPeter, Christiansen PM, Lash TL, Ahern TP. 2013. Use of β-blockers, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and risk of breast cancer recurrence: a Danish nationwide prospective cohort study.. J Clin Oncol. 31(18):2265-72.

2012

Lutgendorf SK, De Geest K, Bender D, Ahmed A, Goodheart MJ, Dahmoush L, M Zimmerman B, Penedo FJ, Lucci JA, Ganjei-Azar P et al.. 2012. Social influences on clinical outcomes of patients with ovarian cancer.. J Clin Oncol. 30(23):2885-90.

2011

Ganz PA, Habel LA, Weltzien EK, Caan BJ, Cole SW. 2011. Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort.. Breast Cancer Res Treat. 129(2):549-56.

2007

Frasure-Smith N, Lespérance F, Irwin MR, Sauvé C, Lespérance J, Théroux P. 2007. Depression, C-reactive protein and two-year major adverse cardiac events in men after acute coronary syndromes.. Biol Psychiatry. 62(4):302-8.